These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23454868)

  • 21. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.
    Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T
    Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.
    Davis H; Lewis A; Behrens A; Tomlinson I
    Gut; 2014 May; 63(5):792-9. PubMed ID: 23676439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression.
    Iriuchishima H; Takubo K; Matsuoka S; Onoyama I; Nakayama KI; Nojima Y; Suda T
    Blood; 2011 Feb; 117(8):2373-7. PubMed ID: 21190997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation.
    Villaruz LC; Socinski MA
    Lung Cancer; 2014 Feb; 83(2):300-1. PubMed ID: 24360397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
    Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
    Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
    Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
    J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of GSK3β-FBXW7-JUNB axis.
    Pérez-Benavente B; Farràs R
    Oncotarget; 2013 Jul; 4(7):956-7. PubMed ID: 23918007
    [No Abstract]   [Full Text] [Related]  

  • 29. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
    Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
    BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.
    Wang Z; Liu Y; Zhang P; Zhang W; Wang W; Curr K; Wei G; Mao JH
    Oncotarget; 2013 Dec; 4(12):2476-86. PubMed ID: 24344117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FBXW7 mutations in melanoma and a new therapeutic paradigm.
    Aydin IT; Melamed RD; Adams SJ; Castillo-Martin M; Demir A; Bryk D; Brunner G; Cordon-Cardo C; Osman I; Rabadan R; Celebi JT
    J Natl Cancer Inst; 2014 Jun; 106(6):dju107. PubMed ID: 24838835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.
    Zhang Q; Karnak D; Tan M; Lawrence TS; Morgan MA; Sun Y
    Mol Cell; 2016 Feb; 61(3):419-433. PubMed ID: 26774286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis.
    Perry JM; Li L
    Genes Dev; 2008 May; 22(9):1107-9. PubMed ID: 18451101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer.
    Liu Y; Ren S; Castellanos-Martin A; Perez-Losada J; Kwon YW; Huang Y; Wang Z; Abad M; Cruz-Hernandez JJ; Rodriguez CA; Sun Y; Mao JH
    PLoS One; 2012; 7(11):e49453. PubMed ID: 23166673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibility.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    PLoS One; 2012; 7(2):e31301. PubMed ID: 22348067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
    Cao J; Ge MH; Ling ZQ
    Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
    Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
    Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
    Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
    Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.